NEW YORK, Sept. 6 – Kosan Biosciences has received a $100,000 Phase I small business innovative research grant from the National Institutes of Health to construct a library of novel ligands to be screened against G protein-coupled receptors.
Registering provides access to this and other free content.
Already have an account?Login Now.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.